I don’t understand the sale price either, even at $450 mil. Initially I figured there’s no way Clone 3 was part of it, so it somewhat made sense back at the time. But now I just don’t get it. There’s gotta be some aspect we aren’t privy to, maybe someone is ready with funding but only once they get out of the otc? So someone like Samsung Bio says, we will fund the trials for so and so but Nasdaq has to happen first. Idk, just thinking aloud trying to make more sense of things. This lawsuit is just dragging those answers out further, so let’s hope that goes away soon so we can just get down to it and find out where this is officially going. I don’t like having this much still tied up in something so up in the air now. But at the same time I cannot bring myself to sell anything at these redic prices.